Drugs / Mel
last change Dec 2025 re-read 9 days ago

Mel

Developed for
disease related to hematopoietic stem cell transplant
Investigated by
First Affiliated Hospital Xi'an Jiaotong University

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05814718 Apr 2023 → Dec 2025 disease related to hematopoietic stem cell transplant First Affiliated Hospital Xi'an Jiaotong University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mel “Mel 140mg/m2,-2d” NCT05814718 ↗